Keybanc Maintains Overweight on Progyny, Raises Price Target to $35
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $30 to $35.
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $30 to $35.